CD4 and plasma cell myeloma: Blockade of this axis using an anti-PD-L1 Ab increases CD4+ T cell proliferation and CTL activity against human MM cells in vitro (120) and is curative in a murine model of myeloma in combination with antagonists of the IAP (inhibitors of apoptosis) proteins (121).